Advertisement

The impact of tunnelled vascular catheters on time to arteriovenous fistula creation

The impact of tunnelled vascular catheters on time to arteriovenous fistula creation

Post author correction

Article Type: ORIGINAL ARTICLE

Article Subject: Dialysis

DOI:10.5301/jva.5000454

Authors

Hareeshan Nandakoban, Ananthakrishnapuram Aravindan, Tim Spicer, Govind Narayanan, Noemir Gonzalez, Michael Suranyi, Jeffrey K.W. Wong

Corresponding author

  • Hareeshan Nandakoban
  • Renal Unit, Liverpool Hospital
  • Sydney, NSW 2170, Australia
  • hari.nandakoban@sswahs.nsw.gov.au

Abstract

The purpose of this study is to examine the effect of the presence of tunnelled vascular catheter (TVC) on physician referral and surgeon review and operating patterns and ultimately time of creation of permanent haemodialysis (HD) access.

A retrospective analysis of TVC and arteriovenous fistulae (AVF) databases in 2010. Physician referral time and surgical time to operation were compared between patients commencing HD with TVC and a control group who commenced HD with AVF.

The AVF group (n = 27) commenced HD with an AVF and TVC group (n = 49) commenced HD via a TVC. Time from physician referral to surgeon review in the AVF vs. TVC group was 29 vs. 35 days (p = 0.6). Time from surgeon review to access creation was 43 vs. 50 days (p = 0.4). However, in the TVC group, the time from TVC insertion to physician referral to a surgeon was an additional 109 ± 20 days. Subgroup analysis of 11 TVC patients (23%) presenting at end stage without AVF (crash starters) had a TVC to physician referral time of 103 ± 75 days, physician referral to surgeon review of 14.4 ± 4 days and surgeon review to AVF of 67 ± 23 days.

The presence of a TVC is associated with a significant delay (>3 months) before physicians make a referral for surgeon review. There was no surgeon-related delay to access creation related to the presence of a TVC.

Article History

Disclosures

Financial support: The authors have no financial disclosures to make.
Conflict of interest: The authors have no conflict of interest.
Meeting presentation: This study was presented as a Poster at the Australia and New Zealand Society of Nephrology Annual Scientific Meeting in 2011.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Nandakoban, Hareeshan [PubMed] [Google Scholar] , * Corresponding Author (hari.nandakoban@sswahs.nsw.gov.au)
  • Aravindan, Ananthakrishnapuram [PubMed] [Google Scholar]
  • Spicer, Tim [PubMed] [Google Scholar]
  • Narayanan, Govind [PubMed] [Google Scholar]
  • Gonzalez, Noemir [PubMed] [Google Scholar]
  • Suranyi, Michael [PubMed] [Google Scholar]
  • Wong, Jeffrey K.W. [PubMed] [Google Scholar]

Affiliations

  • Renal Unit, Liverpool Hospital, Sydney, New South Wales - Australia

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.